IDEX Biometrics ASA
Other OTCTotal Valuation
IDEX Biometrics ASA carries a market capitalization of 68.80M, placing it among publicly traded companies globally. Its enterprise value stands at 50.65M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 68.80M |
| Enterprise Value | 50.65M |
Share Statistics
IDEX Biometrics ASA currently has 62.60M shares outstanding.
| Shares Outstanding | 62.60M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
The price-to-sales ratio is 194.61, and the price-to-book ratio stands at 4.31.
| PE Ratio | N/A |
| PS Ratio | 194.61 |
| PB Ratio | 4.31 |
| P/TBV Ratio | 50.13 |
| P/FCF Ratio | -5.75 |
| P/OCF Ratio | -5.75 |
Enterprise Valuation
| EV / Sales | 199.41 |
| EV / EBITDA | N/A |
| EV / EBIT | N/A |
| EV / FCF | N/A |
Financial Position
IDEX Biometrics ASA maintains a current ratio of 1.58, meaning it holds 1.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 132.53, indicating elevated leverage, while an interest coverage ratio of -13.10 demonstrates limited ability to service its debt obligations.
| Current Ratio | 1.58 |
| Quick Ratio | 0.16 |
| Debt / Equity | 132.53 |
| Debt / EBITDA | -0.18 |
| Interest Coverage | -13.10 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -111.51 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 0.51 |
Taxes
| Income Tax | -41,000.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
IDEX Biometrics ASA's stock has gained approximately 345% over the past 52 weeks. The 50-day moving average sits at 0.28, while the 200-day moving average is 0.22.
| Beta (5Y) | N/A |
| 52-Week Price Change | 345% |
| 50-Day Moving Average | 0.28 |
| 200-Day Moving Average | 0.22 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, IDEX Biometrics ASA generated 254,000.00 in revenue and converted that into -10.00M in net income, yielding earnings per share of -0.41. EBITDA reached -10.53M, while operating income came in at -10.53M.
| Revenue | 254,000.00 |
| Gross Profit | -2.60M |
| Operating Income | -10.53M |
| Pretax Income | -10.04M |
| Net Income | -10.00M |
| EBITDA | -10.53M |
| EBIT | -10.53M |
| Earnings Per Share (EPS) | -0.41 |
Balance Sheet
IDEX Biometrics ASA holds 715,000.00 in cash and equivalents against 1.94M in total debt, resulting in a net debt position of 1.14M. Total book value stands at 11.46M, with working capital of 2.60M providing operational flexibility.
| Cash & Cash Equivalents | 715,000.00 |
| Total Debt | 1.94M |
| Net Debt | 1.14M |
| Equity (Book Value) | 11.46M |
| Book Value Per Share | 0.47 |
| Working Capital | 2.60M |
Cash Flow
IDEX Biometrics ASA produced -8.60M in operating cash flow over the past twelve months.
| Operating Cash Flow | -8.60M |
| Capital Expenditures | N/A |
| Free Cash Flow | -8.60M |
| FCF Per Share | -0.35 |
Margins
IDEX Biometrics ASA operates with a gross margin of -1,022.05, reflecting its pricing power and cost economics. The operating margin of -4,145.28 and net profit margin of -3,936.61 provide insight into operational efficiency.
| Gross Margin | -1,022.05 |
| Operating Margin | -4,145.28 |
| Pretax Margin | -3,953.15 |
| Profit Margin | -3,936.61 |
| EBITDA Margin | -4,145.28 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | -14.81 |
| FCF Yield | -17.40 |
Stock Splits
IDEX Biometrics ASA's most recent stock split took place on July 7, 2025 with a 100:1 split ratio.
| Last Split Date | 7/7/2025 |
| Split Ratio | 100:1 |
Scores
IDEX Biometrics ASA posts an Altman Z-Score of 1.45, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.45 |